Maria V Cortes, | |
Gk 33 Ave Roberto Sanchez Vilella Suite A2, Ave Campo Rico, Carolina, PR 00982 | |
(787) 556-3399 | |
Not Available |
Full Name | Maria V Cortes |
---|---|
Gender | Female |
Speciality | Psychologist |
Location | Gk 33 Ave Roberto Sanchez Vilella Suite A2, Carolina, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770048928 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 4199 (Puerto Rico) | Secondary |
103T00000X | Psychologist | 6197 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Maria V Cortes, Po Box 706, Guaynabo, PR 00970-0706 Ph: (787) 644-9665 | Maria V Cortes, Gk 33 Ave Roberto Sanchez Vilella Suite A2, Ave Campo Rico, Carolina, PR 00982 Ph: (787) 556-3399 |
News Archive
Six faculty members at the University of South Florida in Tampa have been named Fellows of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers.
A study conducted at The Wistar Institute in collaboration with The University of Texas Southwestern Medical Center has demonstrated the efficacy of targeting aberrantly active telomerase to treat therapy-resistant melanoma.
Scientists at the Ottawa Hospital Research Institute and the University of Ottawa have discovered what may be an important clue to the cause of type 1 diabetes. Dr. Fraser Scott and his team tested 42 people with type 1 diabetes and found that nearly half had an abnormal immune response to wheat proteins. The study is published in the August 2009 issue of the journal Diabetes.
Chocolate, coffee and cola are perhaps three of your favourite consumables; however, they are also three caffeine-rich substances which all contribute to your daily caffeine consumption. According to the BBC, people should not exceed 400mg caffeine a day, and this limit halves for pregnant women, for which only 200mg/day is recommended.
Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces it has entered into a multi-step collaboration with XOMA Corporation, a leader in the discovery and development of therapeutic antibodies.
› Verified 1 days ago